These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1470207)

  • 21. Accumbal dopamine and serotonin activity throughout acquisition and expression of place conditioning: correlative relationships with preference and aversion.
    Weitemier AZ; Murphy NP
    Eur J Neurosci; 2009 Mar; 29(5):1015-26. PubMed ID: 19245370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain substrates for increased drug seeking during protracted withdrawal.
    Aston-Jones G; Harris GC
    Neuropharmacology; 2004; 47 Suppl 1():167-79. PubMed ID: 15464135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in dopamine responsiveness to drugs of abuse in the nucleus accumbens shell and core of Lewis and Fischer 344 rats.
    Cadoni C; Di Chiara G
    J Neurochem; 2007 Oct; 103(2):487-99. PubMed ID: 17666048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Characteristics and functions of intraneuronal compartments of monoamines in the central nervous system].
    Gowinski J; Besson MJ; Cheramy A; Javoy F; Thierry AM
    Rev Neurol (Paris); 1972 Jul; 127(1):1-22. PubMed ID: 4677511
    [No Abstract]   [Full Text] [Related]  

  • 25. Contributions of 5-HT(2C) receptors to multiple actions of central serotonin systems.
    Giorgetti M; Tecott LH
    Eur J Pharmacol; 2004 Mar; 488(1-3):1-9. PubMed ID: 15044029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurochemical and behavioral responses to cocaine in adult male rats with neonatal isolation experience.
    Kosten TA; Zhang XY; Kehoe P
    J Pharmacol Exp Ther; 2005 Aug; 314(2):661-7. PubMed ID: 15845857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurochemical mechanisms involved in behavioral effects of amphetamines and related designer drugs.
    Gold LH; Geyer MA; Koob GF
    NIDA Res Monogr; 1989; 94():101-26. PubMed ID: 2514360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholinergic and adrenergic effects of atropine and physostigmine on brain chemistry and learned behavior.
    Flynn A
    Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):173-80. PubMed ID: 4671884
    [No Abstract]   [Full Text] [Related]  

  • 29. Enhanced locomotor activity in rats with excitotoxic lesions of the entorhinal cortex, a neurodevelopmental animal model of schizophrenia: behavioral and in vivo microdialysis studies.
    Sumiyoshi T; Tsunoda M; Uehara T; Tanaka K; Itoh H; Sumiyoshi C; Kurachi M
    Neurosci Lett; 2004 Jul; 364(2):124-9. PubMed ID: 15196692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How can drug addiction help us understand obesity?
    Volkow ND; Wise RA
    Nat Neurosci; 2005 May; 8(5):555-60. PubMed ID: 15856062
    [No Abstract]   [Full Text] [Related]  

  • 31. Reinforcing properties of inhaled substances.
    Wood RW
    Neurobehav Toxicol; 1979; 1 Suppl 1():67-72. PubMed ID: 400898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Backward walking and circling: a behavioural response to concurrent catecholamine and 5-hydroxytryptamine release [proceedings].
    Curzon G; Fernando JC; Lees AJ
    Br J Pharmacol; 1979 May; 66(1):119P-120P. PubMed ID: 454915
    [No Abstract]   [Full Text] [Related]  

  • 33. [Interactions between dopamine, serotonin and other internal reinforcement factors].
    Koroleva SV; Nikolaeva AA; Ashmarin IP
    Izv Akad Nauk Ser Biol; 2006; (4):457-69. PubMed ID: 17022478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurochemical predictors and correlates of vulnerability to cocaine use.
    King RJ; Flowers C
    NIDA Res Monogr; 1996; 159():228-63; discussion 264-8. PubMed ID: 8784861
    [No Abstract]   [Full Text] [Related]  

  • 35. Microdialysis coupled with electrochemical detection. A way to investigate brain monoamine role in freely moving animals.
    Carboni E
    Methods Mol Med; 2003; 79():415-32. PubMed ID: 12506714
    [No Abstract]   [Full Text] [Related]  

  • 36. Serotonin neurotoxins.
    Ann N Y Acad Sci; 1978 Jun; 305():1-665. PubMed ID: 280243
    [No Abstract]   [Full Text] [Related]  

  • 37. Opponency revisited: competition and cooperation between dopamine and serotonin.
    Boureau YL; Dayan P
    Neuropsychopharmacology; 2011 Jan; 36(1):74-97. PubMed ID: 20881948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavioral pharmacologists: don't just say "no" to knockout mice. Commentary on Stephens et al. 'Studying the neurobiology of stimulant and alcohol abuse and dependence in genetically manipulated mice'.
    Caine SB; Ralph-Williams RJ
    Behav Pharmacol; 2002 Sep; 13(5-6):349-52. PubMed ID: 12394409
    [No Abstract]   [Full Text] [Related]  

  • 39. Insulin regulation of monoamine signaling: pathway to obesity.
    Niswender KD; Daws LC; Avison MJ; Galli A
    Neuropsychopharmacology; 2011 Jan; 36(1):359-60. PubMed ID: 21116253
    [No Abstract]   [Full Text] [Related]  

  • 40. Individual differences in addictive liability: associated behavioral and biochemical features.
    Mittleman G
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():249A-250A. PubMed ID: 1498829
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.